• DiscoveryProbe Bioactive Compound Library Plus in High-Throu

  2026-06-05

  The DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) revolutionizes high-throughput ligand screening with 5,072 rigorously validated, cell-permeable compounds. Its ready-to-use 10 mM DMSO solutions, robust QC, and pathway diversity enable advanced workflows for cancer, apoptosis, and immunology research—supported by insights from the latest ligand-screening innovations.

• Saquinavir: Optimizing HIV Protease Inhibitor Workflows

  2026-06-04

  Saquinavir empowers researchers to model HIV and cancer pathways with high reproducibility, leveraging robust inhibition of HIV-1 and HIV-2 proteases. This article reveals protocol enhancements, biomimetic membrane insights, and troubleshooting tactics that maximize Saquinavir’s impact in both antiretroviral drug and permeability studies.

• Endothelial SGK1 Drives Vascular Stiffening via Salt-Induced

  2026-06-04

  This study demonstrates that endothelial SGK1 is a critical mediator of vascular stiffening induced by high salt and mineralocorticoid signaling. Using genetic models and selective inhibition with EMD638683, the research clarifies the molecular mechanisms linking sodium handling, actin polymerization, and increased arterial stiffness, offering new mechanistic insights for hypertension and cardiovascular research.

• Monomethyl auristatin E: Precision Payload for ADC Cancer Mo

  2026-06-03

  Monomethyl auristatin E (MMAE) empowers translational labs to design next-generation antibody-drug conjugate (ADC) workflows with unrivaled cytotoxic precision. This guide synthesizes protocol tips, troubleshooting insights, and experimental innovations—including strategies to address tumor plasticity—drawing on breakthrough research and APExBIO’s trusted MMAE supply.

• 2'3'-cGAMP (Sodium Salt): Precision Tool for cGAS-STING Rese

  2026-06-03

  2'3'-cGAMP (sodium salt) is redefining the landscape of STING-mediated innate immunity research. This article blends mechanistic insights with strategic advice for translational scientists, connecting landmark evidence on NAD depletion-driven mitochondrial DNA leakage and cGAS-STING activation to actionable experimental strategies. By situating APExBIO’s reagent within this evolving paradigm, we offer a roadmap for leveraging 2'3'-cGAMP in foundational and disease-relevant settings, while critically appraising its translational potential and current boundaries.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-06-02

  The AO/PI Double Staining Kit offers a rapid, fluorescence-based solution for distinguishing live, apoptotic, and necrotic cells within a single assay. It is best used for cell viability assessments and apoptosis/necrosis detection in research workflows requiring clear population discrimination. It should not be used for non-fluorescent applications or for mechanistic cell death studies beyond AO/PI signal resolution.

• DMH1 as a Precision ALK2 Inhibitor for Organoid and NSCLC Re

  2026-06-02

  DMH1 enables highly selective inhibition of BMP signaling, empowering researchers to fine-tune organoid differentiation and suppress non-small cell lung cancer cell proliferation with validated specificity. This article distills experimental workflows, troubleshooting strategies, and novel insights from recent breakthroughs, positioning DMH1 as a cornerstone for next-generation disease modeling.

• Estradiol–Autophagy Axis in Multi-Organ Protection During Pe

  2026-06-01

  This study reveals how the decline of estradiol during perimenopause compromises heart, aorta, and kidney health via disruption of the estrogen receptor–autophagy pathway. Integrating human cohort data, network pharmacology, and mouse models, the research offers mechanistic insights into estrogen’s organ-protective roles and informs precision strategies for hormone therapy and disease prevention.

• 2-Deoxy-D-glucose: Applied Workflows for Glycolysis Inhibiti

  2026-06-01

  2-Deoxy-D-glucose (2-DG) is a robust glycolysis inhibitor that empowers metabolic, cancer, and virology research with quantitative reproducibility and workflow flexibility. This article distills experimental best practices and troubleshooting tips, drawing on recent studies and vendor benchmarks, to help scientists optimize 2-DG’s use in metabolic stress and pathway modulation assays.

• Synthetic Viability in ERCC1-Deficient Lung Cancer: p53's Ro

  2026-05-31

  This study uncovers how p53 status modulates synthetic viability and DNA repair in ERCC1-deficient lung cancer cells exposed to interstrand crosslinking agents. The findings have significant implications for refining platinum-based chemotherapy response biomarkers and understanding mechanisms of resistance.

• Translating Src Kinase Inhibition: PP 1 in Oncology & Immuno

  2026-05-30

  This article bridges advanced mechanistic insights with actionable strategies for translational researchers aiming to leverage PP 1, a potent Src family tyrosine kinase inhibitor, in cancer and immunology studies. We explore the biological rationale for targeting Src kinases, showcase experimental and clinical validation—including recent findings on kinase inhibitor side effects—and provide guidance for implementing PP 1 in cutting-edge workflows. Distinct from conventional product summaries, this discussion integrates cross-domain learnings and offers a forward-looking perspective for optimizing translational impact.

• CX-5461: Advancing Pol I Inhibition for Cancer Translation

  2026-05-29

  Explore the mechanistic foundation and translational strategy for leveraging the RNA polymerase I inhibitor CX-5461 in cancer research. This thought-leadership article synthesizes emerging evidence from cervical and solid tumor models, addresses experimental design, highlights APExBIO’s product leadership, and offers a forward-looking perspective on autophagy and senescence induction as next-generation anticancer strategies.

• Metronidazole: Applied OAT3 Inhibition for Translational Res

  2026-05-29

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) transcends its antibiotic role by enabling precision modulation of organic anion transporters in advanced research. This guide delivers actionable workflows, troubleshooting strategies, and comparative insights for maximizing its impact in drug interaction studies, microbiota research, and beyond.

• Ultrasound-Triggered Piezo-Nanoplatforms for Non-Invasive Ep

  2026-05-28

  This study introduces a biomimetic piezoelectric nanoplatform capable of ultrasound-triggered neuromodulation and co-delivery of antiepileptic drugs, offering a non-invasive alternative for epilepsy treatment. The platform's dual-action design addresses the limitations of conventional implant-based therapies and drug regimens, potentially transforming clinical strategies for drug-resistant epilepsy.

• Lanabecestat (AZD3293): Synaptic Safety and Dosing Insights

  2026-05-28

  Discover how Lanabecestat (AZD3293) enables safe, effective amyloid-beta pathway modulation in Alzheimer's disease research. This article uniquely explores synaptic transmission data and dosing strategies, grounded in recent mechanistic findings.

456 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page